Title Page
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - September 15, 2015 Category: Cardiology Source Type: research
Information for Readers
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - September 15, 2015 Category: Cardiology Source Type: research
Table of Contents
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - September 15, 2015 Category: Cardiology Source Type: research
Foreword
The life span of people has been increasing. As a result, there are more individuals who are “older”. In these individuals, there is an increased prevalence of calcific aortic stenosis (AS) which have a variety of associated cardiac and non-cardiac disorders which may require non-cardiac surgery. At the same time, because of advances in the management of surgical aortic valve replacement (SAVR), there is a common clinical decision making issue. The management of such patients who have AS of variable severity both with regard to AS and the need for non-cardiac surgery is critical. (Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - September 14, 2015 Category: Cardiology Authors: Shahbudin H. Rahimtoola Source Type: research
Editorial Board
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - August 15, 2015 Category: Cardiology Source Type: research
Title Page
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - August 15, 2015 Category: Cardiology Source Type: research
Information for Readers
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - August 15, 2015 Category: Cardiology Source Type: research
Table of Contents
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - August 15, 2015 Category: Cardiology Source Type: research
Editorial Board
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - June 19, 2015 Category: Cardiology Source Type: research
Title Page
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - June 19, 2015 Category: Cardiology Source Type: research
Information for Readers
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - June 19, 2015 Category: Cardiology Source Type: research
Table of Contents
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - June 19, 2015 Category: Cardiology Source Type: research
Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects
Brugada syndrome (BrS) is an inherited cardiac arrhythmia syndrome first described as a new clinical entity in 1992. Electrocardiographically characterized by distinct coved type ST segment elevation in the right-precordial leads, the syndrome is associated with a high risk for sudden cardiac death in young adults, and less frequently in infants and children. The electrocardiographic manifestations of BrS are often concealed and may be unmasked or aggravated by sodium channel blockers, a febrile state, vagotonic agents, as well as by tricyclic and tetracyclic antidepressants. (Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - June 11, 2015 Category: Cardiology Authors: Charles Antzelevitch, Bence Patocskai Source Type: research
Brugada syndrome. Clinical, Genetic, Molecular
The Brugada syndrome (BrS) is an inherited cardiac arrhythmia syndrome first described as a new clinical entity in 1992. Electrocardiographically characterized by distinct coved type ST segment elevation in the right precordial leads, the syndrome is associated with a high risk for sudden cardiac death in young adults, and less frequently in infants and children. The ECG manifestations of the BrS are often concealed and may be unmasked or aggravated by sodium channel blockers, a febrile state, vagotonic agents, as well as by tricyclic and tetracyclic antidepressants. (Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - June 11, 2015 Category: Cardiology Authors: Charles Antzelevitch, Bence Patocskai Source Type: research
Left Atrial Appendage Occlusion For Stroke Prevention
Atrial fibrillation (AF) remains the most common arrhythmia encountered in clinical practice. One of its more common deleterious effects is the development of thromboembolism leading to stroke. The left atrial appendage (LAA) has been shown to the site of the majority of thrombus formation leading to stroke. Anticoagulation with warfarin has been the treatment of choice for prevention of embolic events. Newer anticoagulants have been developed but they still have the potential side effect of causing major bleeding. (Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - June 11, 2015 Category: Cardiology Authors: Oluseun O. Alli, David R. Holmes Source Type: research
